Quarterly Sales and EPS Roundup:
Allscripts Healthcare Solutions, Inc. (MDRX) reported sales (ttm) of 1.55 Billion, whereas, 18 number of analysts estimated the mean sale of 426.77 million. The analysts estimated sales for the higher end at 436.8 million and lower end at 420.59 million while the year ago reported sale was 379.4 million.
18 number of analysts have estimated the sales of the company for the quarter ending May 4, 2017, analysts estimated mean sale target of 431.93 million while high and low sale targets are estimated at 439 million and 423.8 million respectively.
Allscripts Healthcare Solutions, Inc. (MDRX) reported earning per shares for the quarter ending May 04 AMC at 0.14, whereas, 22 number of analysts estimated the mean EPS at 0.15. The analysts estimated EPS for the higher end at 0.17 and lower end at 0.14 while the year ago reported earnings per share was 0.17.
The company has mean EPS estimate of 0.16 reported by 22 number of analyst for the quarter ending May 4, 2017. The analysts estimated mean EPS at 0.16 while the high and low EPS estimate stand at 0.17 and 0.14 respectively. In contrast to the year ago quarter EPS was at 0.18. EPS long term mean growth rate estimated by 2 analysts is at 16.5%, whereas, the high and low Long term growth rate estimated at 18 and 15.
Valuation Ratios of Allscripts Healthcare Solutions, Inc. (MDRX) versus the Industry and Sector:
Let’s have a look at some of the important valuation ratios of the Allscripts Healthcare Solutions, Inc. (MDRX). These ratios are important while doing valuation of the company or the shares of the company.
Allscripts Healthcare Solutions, Inc. (MDRX) currently has P/E (Price to Earnings) ratio of 0 while the company’s industry has 49.81 P/E and the sector P/E is 29.67. Similarly, the company’s last 5 years high P/E ratio is 0 and low P/E is 0, whereas, the industry’s and sector’s high P/E for the past year is 74.16 and 44.5 respectively and low P/E ratio for the last 5 years is 23.7 for the industry and 23.02 for the Sector.
Beta is also an important valuation ratio for analyzing the stock of the company, MDRX has Beta of 1.32 while its industry and Sector’s beta remains at 0.81 and 0.82 respectively.
Price to Sale ratio of MDRX stands at 1.38 while Price to Book Ratio stands at 1.73. Its Price to Cash Flow ratio shows the value of 14.57, whereas, the industry and sector ratio of Price to Cash Flow ticked at 18.91 and 22.87 respectively.
5 Year Growth Rate Analysis:
Growth rates are very important while analyzing the long term growth and valuation of a certain company.
5 year sales growth rate is an important factor for valuation analysis, the 5 year sales growth of Allscripts Healthcare Solutions, Inc. (MDRX) stands at 1.42 while the industry’s and the sector’s growth for next 5 years ticked at 3.83 and 10.73 respectively. The company’s 5 year Earnings per share growth and Capital Spending growth remains at 0 and 5.6.
Allscripts Healthcare Solutions, Inc. (MDRX) Trading Statistics:
The company surged 0.85% and closed its last trading session at $11.79. The market capitalization of the company is at $2.16 Billion. The stock touched 52-week High of $15.17 on 08/05/16 and 52-week Low of $9.80 on 11/09/16. The stock currently has Weekly Volatility of 2.17% and Monthly Volatility of 2.49%. The Beta for the company stands at 1.31 and its Average True Range (ATR) shows a value of 0.29.